Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8713511 | Journal of Allergy and Clinical Immunology | 2018 | 30 Pages |
Abstract
Identification of excessive IFN-γ production by blood and lymph node-derived T cells of patients with CVID with immune dysregulation will offer new therapeutic avenues for this subgroup. CD21low B cells might serve as a marker of this IFN-γ-associated dysregulation.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Susanne MSc, Maximilian MD, Pauline PhD, Mirzokhid PhD, Alla PhD, Natalie MD, Bodo MD, Jens MD, Klaudia Schrenk, Luis MD, PhD, Leif MD, Ina Stumpf, Fabian MD, Oliver MD, Florian MD, Sigune MD, Mirjam PhD, Baerbel PhD, Klaus MD,